PLEASANTON, Calif. and Boston – June, 2017 – NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology, today announced presentation of the five-year results of the pivotal, randomized L.I.F.T. IDE study, which evaluated the safety and effectiveness of the company’s novel UroLift® System as a treatment for patients with symptomatic benign prostatic hyperplasia (BPH) or enlarged Prostate.  
Claus Roehrborn, M.D., Professor and Chair of the Department of Urology UT Southwestern Medical Center in Dallas and co-principal investigator for the L.I.F.T. … Continue reading NeoTract Inc. Announces Positive Five-Year Results for Minimally Invasive UroLift® System at American Urological Association 2017 Meeting